| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.021 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0055 | 0.9 |